| |
Ankylosing Spondylitis | |
The following sources are recommended by a professor whose research specialty is ankylosing spondylitis and other forms of arthritis. |
· Brewerton DA, Hart FD, Nicholls A, et al. "Ankylosing Spondylitis and HL-A27." Lancet 1973; 1:904-07.
· Brown MA, Kennedy LG, MacGregor AJ, et al. "Susceptibility to Ankylosing Spondylitis in Twins: The Role of Genes, HLA, and the Environment." Arthritis and Rheumatism 1997; 40:1823-28.
· Calin A, Taurog J (eds.). The Spondylarthritides. Oxford University Press, 1998.
· Khan MA. Ankylosing Spondylitis: The Facts. Oxford University Press, 2002.
· Roddis M, Carter RW, Sun MY, Weissensteiner T, et al. "Fully Functional HLA B27-Restricted CD4+ as well as CD8+ T Cell Responses in TCR Transgenic Mice." Journal of Immunology 2004; 172(1):155-61.
· Spondylitis Association of America. http://www.spondylitis.org/
· Dieppe P, Wollheim FA, Schumacher HR (eds.). Classical Papers in Rheumatology. Martin Dunitz, 2002.
· Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. "How to Diagnose Axial Spondyloarthritis Early." Annals of The Rheumatic Diseases 2004; 63:535-43.
· Van Der Heijde D. "New Directions in Classification and Outcome Assessment in Ankylosing Spondylitis." Current Rheumatology Reports 2004; 6(2):98-101.
· Ward MM. "Outcome Measurement: Health Status and Quality of Life." Current Opinion in Rheumatology 2004; 16(2):96-101.
· Brandt J, Khariouzov A, Listing J, et al. "Successful Short Term Treatment of Patients with Severe Undifferentiated Spondyloarthritis with the Anti-Tumor Necrosis Factor-Alpha Fusion Receptor Protein Etanercept." Journal of Rheumatology 2004; 31(3):531-38.
· Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J. "Prediction of a Major Clinical Response (BASDAI 50) to Tumour Necrosis Factor Alpha Blockers in Ankylosing Spondylitis." Annals of the Rheumatic Diseases 2004; 63:665-70.
· Boyle LH, Goodall JC, Gaston JS. "Major Histocompatibility Complex Class I-Restricted Alloreactive CD4 T Cells." Immunology. 2004; 112(1):54-63.
· Khan MA. "Ankylosing Spondylitis: Introductory Comments on Its Diagnosis and Treatment." New Treatment Strategies in Ankylosing Spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002. Annals of the Rheumatic Diseases 2002; 61(Suppl 3):iii3-iii7.
· Feldtkeller E, Khan MA, van der Linden S, van der Heijde D, Braun J. "Age at Disease Onset and Diagnosis Delay in HLA-B27 Negative vs. Positive Patients with Ankylosing Spondylitis." Rheumatology International 2003; 23:61-66.
· Khan MA. "Update on Spondyloarthropathies." Annals of Internal Medicine 2002; 136:896-907.
· Khan MA. "HLA-B27 and Its Subtypes in World Populations." Current Opinion in Rheumatology 1995; 7:263-69.
"The Infography about Ankylosing Spondylitis"
http://www.infography.com/content/587024652672.html
© 2009 Fields of Knowledge
Essex, Iowa 51638-4608 USA